Factors determining survival in oligometastatic breast cancer in a retrospective cohort study from a low and middle income country

Document Type

Article

Department

Breast Surgery

Abstract

Metastatic breast cancer has historically had a poor prognosis, but oligometastatic breast cancer shows differing outcomes. We analyzed the factors affecting 5-year survival for patients undergoing upfront resection. We conducted a 10-year chart review from a tertiary referral hospital. Patients were followed for at least 5 years after surgery. Overall and progression free survival were calculated from date of surgery using cox-proportional hazards while logistic regression was used to evaluate the pre- and post-operative factors associated with surgery. 55 patients with a mean age of 50.4 years were included. Most patients had T4, N1/N2 stage disease on presentation. The most common site of metastasis was lungs. The median overall survival was 111 months with a 5-year survival rate of 64.6% (47.9%, 77.2%). There were 18 distant and 1 local recurrence and 20 deaths in our cohort leading to a median progression free survival of 36 months. N2 nodal disease, and liver metastasis were identified as poor prognostic markers while hormone receptors increased survival (p < 0.05), while locally advanced disease and triple positive tumor biology increased the risk of progression and death (p < 0.05). Patients with limited metastatic disease should be considered for upfront resection with the intent to cure, especially when triple positive tumor biology is present.

Comments

Pagination is not provided by author/publisher.

AKU Student

no

Publication (Name of Journal)

Scientific Reports

DOI

10.1038/s41598-025-18342

Link to Full Text

Share

COinS